J-Pharma
IPODeveloping innovative new drugs targeting SLC transporters
Tokyo, Japan · Founded 2005 · $49.6M raised
- Headquarters
- Tokyo
- Employees
- 1–10
- Founded
- 2005
- Business Model
- B2B
- Website
- j-pharma.com
- Total Funding
- $49.6M
- Last Round
- $23.7M Venture RoundApr 2025
- Rounds
- 4
About
J-Pharma Co., Ltd. is a Tokyo-based clinical-stage biopharmaceutical company founded in December 2005, focused on developing novel drugs that target SLC (solute carrier) membrane transporters to address unmet medical needs. The company's lead compound, Nanvuranlat (JPH203), is a first-in-class LAT1 inhibitor currently in global Phase III clinical trials for the second-line treatment of biliary tract cancer, having received FDA Orphan Drug Designation in 2022 and FDA IND clearance in 2024. J-Pharma also advances JPH034, a CNS-penetrant LAT1 inhibitor entering Phase I trials for multiple sclerosis. The company was founded based on research by Hitoshi Endou at Kyorin University and listed on the Tokyo Stock Exchange Growth Market in March 2026.
Summary
J-Pharma is a Biotech company based in Tokyo, Japan, founded in 2005. It has raised $49.6M in total across 4 rounds, most recently a $23.7M Venture Round round in Apr 2025. Investors include JIC Venture Growth Investments, Eight Roads Ventures and F-Prime Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Mar 2026
Sign up to see all 5 rounds
Series D through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/j-pharma"><img src="https://indexed.vc/api/badge/company/j-pharma" alt="J-Pharma on Indexed.vc" width="260" height="76" /></a>